Imagine a hospital ward 100 years from now. Will multi-drug resistant infections be as prominent as they are today? I suspect so, because as antibiotics evolve, so will the infectious diseases they target. It's an arms race in which both sides have a capacity to learn and adapt. Not so cancer. Cancers can't learn from each other. But cancer patients can. This profound imbalance in the capacity for learning is an advantage that all cancer patients share. It is our super power. And we barely use it.
NCI may need to invest at least $125 million in new money in the Research Project Grant pool in 2018 if the institute plans on keeping the success rates for R01s comparable to 2017, said NCI Director Ned Sharpless.
What a difference a week makes.
A group of tobacco control advocates, one of whom receives money from Philip Morris International, issued a press release trumpeting that “E-Cigarettes are Saving Lives,” and attributed this conclusion to a recent report by the National Academy of Sciences, Engineering, and Medicine.
Cancer Research UK has shortlisted ten multidisciplinary, international teams for what amounts to the second leg of competition for Grand Challenge awards.
So, the federal government shut down while America slept, but it reopened after a five-and-a-half hour pause, by early morning Feb. 9. We've seen this dance before.
Jon M. Huntsman Sr. dared to eradicate cancer from the face of the earth. People thought he was crazy, but for someone who started out delivering fresh eggs as a boy to support his family, went on to invent and then manufacture the polystyrene egg carton, and built from scratch a $12 billion global chemical company with more than 12,000 employees, there was no holding him back. Jon was a dreamer, a risk-taker, a true visionary, and a man whose compassion for others knew no limits. He didn’t sleep. His life was dedicated to making the world a better place: a world without homelessness, a world without hunger, a world without cancer.
Withholding e-cigarettes as an alternative from smokers who are unable to quit equals supporting the continued use of conventional cigarettes, said David Abrams, a member of the National Tobacco Reform Initiative.
Concurrent FDA approval and the establishment of Medicare coverage will propel Next generation sequencing squarely into the mainstream of oncology practice, said Vincent Miller, chief medical officer of Foundation Medicine Inc.
